Hesperetin (Flavanone · Cardiovascular · Neuroprotective)
| Compound | Hesperetin |
| Chemical class | Polyphenol — Flavanone (Hesperidin aglycone) |
| CAS | 520-33-2 |
| Primary source | Citrus sinensis, Citrus aurantium (orange peel) |
| Key applications | Cardiovascular, anti-inflammatory, neuroprotective |
| Claim strength | Moderate |
| Typical form | Hesperidin hydrolysis product; citrus extract |
Name origin: Hesperetin is the aglycone of hesperidin — formed by removal of the rutinose disaccharide. Hesperidium refers to the berry-like fruit characteristic of citrus species, from which this compound class (hesperidinoids) is derived. Traditional use: Citrus peel preparations have been used across Mediterranean, Indian (Ayurveda), and East Asian (TCM) traditions for vascular, digestive, and respiratory support. Hesperidin and its aglycone hesperetin are central to the pharmacology of these preparations. Research trajectory: Hesperetin has a growing evidence base in its own right, separate from hesperidin, because the aglycone has superior membrane permeability and different metabolic handling. Research covers endothelial function, neuroinflammation, and metabolic syndrome. Commercial source: Accessible via citrus peel extract and via enzymatic or chemical hydrolysis of hesperidin; isolated hesperetin is available in specialist supply.
Evidence for Hesperetin Applications
Cardiovascular and endothelial function: Hesperetin improves endothelial NO production in cell models, supporting vasodilation. Animal studies document reduced blood pressure, improved lipid profiles, and reduced atherosclerotic plaque formation. Human data derive primarily from hesperidin trials, with bioavailability studies showing that hesperetin is the primary circulating metabolite after hesperidin ingestion — meaning hesperidin clinical evidence is partly hesperetin pharmacology. Claim strength: Moderate.
Neuroprotective and cognitive: Hesperetin crosses the blood-brain barrier and suppresses neuroinflammation via NF-κB and NLRP3 inhibition. Animal models of Alzheimer’s show reduced amyloid-beta burden and improved cognitive scores. More lipophilic than hesperidin, hesperetin has superior CNS penetration. Claim strength: Emerging.
Anti-inflammatory and metabolic: Hesperetin inhibits COX-2, NF-κB, and AMPK-related pathways modulating glucose metabolism. Animal models of type 2 diabetes show improved insulin sensitivity. Relevant for metabolic syndrome and joint health formulation positions. Claim strength: Moderate.
Citrus Sinensis Orange Peel Extract Powder →
Orange Powder - Citrus Sinensis →
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Hesperetin is not widely available as a standalone commercial ingredient at scale. Formulators typically access it through: (1) hesperidin standardised citrus extract (hesperetin is a known active metabolite), or (2) specialist isolated hesperetin (≥95% HPLC) for premium applications. Hesperidin dose in human trials: 500–1000 mg/day, from which plasma hesperetin AUC can be estimated.
For formulations seeking the aglycone specifically: 100–250 mg/day of hesperetin is a working estimate based on metabolite pharmacokinetics from hesperidin studies. Enhanced delivery (micronisation, phospholipid complexation) significantly improves absorption of this low-solubility aglycone.
Hesperetin aqueous solubility is very low (~0.01 mg/mL at pH 7); nanoparticle or cyclodextrin complexation is recommended for liquid formats. Thermostability is good; compatible with hot-fill and spray-drying processes. Amber or opaque packaging required due to light sensitivity.
Frequently Asked Questions — Hesperetin
What is the relationship between hesperidin and hesperetin in terms of bioavailability?
Hesperidin is poorly absorbed intact (requires gut microbial deglycosylation). The resulting hesperetin aglycone is absorbed in the small intestine. After oral hesperidin, hesperetin glucuronide conjugates are the primary circulating forms. Hesperetin supplementation bypasses the deglycosylation step and may yield faster and more consistent plasma levels.
Is hesperetin more effective than hesperidin?
Not necessarily more effective, but differently bioavailable. Hesperetin reaches peak plasma concentrations faster than hesperidin, and absorption is less microbiome-dependent. For individuals with altered gut microbiota (e.g. antibiotic use, IBS), hesperetin may deliver more predictable exposures. For standard populations, hesperidin remains the practical choice due to greater commercial availability and established clinical dataset.
Can hesperetin be positioned as a citrus bioflavonoid in supplement labelling?
Yes. Hesperetin is correctly classified as a citrus bioflavonoid, and this is an accepted ingredient category in many markets. Distinguish it from hesperidin on the label if using an isolated or enriched form, to provide accurate consumer information.
Is hesperetin appropriate for topical formulations?
Yes. Higher lipophilicity than hesperidin improves skin penetration. Hesperetin is used in cosmetic research for anti-inflammatory and skin-brightening applications (tyrosinase inhibition reported in vitro). Inclusion at 0.1–0.5% in emulsion-based skincare is documented in formulation literature.
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery